Sort
27,075 grants matching “cholesterol”
Molecular Pharmacology of NKT Cell Agonists
$727,292Luc Teyton · Scripps Research Institute, The · R01 · FY2016 · AI
Molecular Pharmacology of NKT Cell Agonists
$727,292Luc Teyton · Scripps Research Institute, The · R01 · FY2017 · AI
Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial
$727,286William Martinez · Vanderbilt University Medical Center · R01 · FY2024 · DK
Reducing Black Men's Drug Use and Co-Occurring Negative Mental and Physical Health Outcomes: Intersectionality, Social-Structural Stressors, and Protective Factors
$727,210Ingrid Alisa Bowleg · George Washington University · R01 · FY2018 · DA
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH
$727,159Samuel S Gidding · Geisinger Clinic · R33 · FY2025 · HL
Mechanisms of nonvesicular cholesterol transport
$727,059Peter J Tontonoz · University Of California Los Angeles · R01 · FY2025 · HL
Mechanisms of nonvesicular cholesterol transport
$727,059Peter J Tontonoz · University Of California Los Angeles · R01 · FY2024 · HL
Epidemiology: Oxidative Stress and Early Atherosclerosis
$726,884David R Jacobs · University Of Minnesota · R01 · FY2012 · HL
HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME
$726,708Michael Kim · Habit Design, Inc. · R44 · FY2020 · HL
Endosome Dysfunction in Alzheimer's Disease
$726,648Ralph A. Nixon · New York University School Of Medicine · R01 · FY2021 · AG
T-cell subsets as CVD risk factors in CHS and MESA
$726,570Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
Obstructive sleep apnea, the microbiome and cardiovascular disease
$726,129Gabriel G Haddad · University Of California, San Diego · R01 · FY2022 · HL
HABIT DESIGN: TESTING A NOVEL BEHAVIORAL APPROACH TO CORPORATE WELLNESS IN THE CONTEXT OF METABOLIC SYNDROME
$725,892Michael Kim · Habit Design, Inc. · R44 · FY2021 · HL
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
$725,790Gira Bhabha · Johns Hopkins University · R01 · FY2025 · AI
SIV Pathogenesis in African Green Monkeys and Pigtailed Macaques
$725,728Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · HL
Fetal Antecedents to Depression and Risk for CVD
$725,659Jill M Goldstein · Brigham And Women'S Hospital · R01 · FY2011 · MH
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
$725,614Pankaj Arora · University Of Alabama At Birmingham · R01 · FY2023 · HL
Molecular Dynamics And Vibrational Characteristics Of Membrane Assemblies
$725,342Ira W. Levin · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)
$725,212Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2025 · MD
The Effect of Statins on Skeletal Muscle Function
$725,187Paul Davis Thompson · Hartford Hospital · R01 · FY2008 · HL
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
$725,178Pankaj Arora · University Of Alabama At Birmingham · R01 · FY2024 · HL
CONTROL OF CHOLESTEROL METABOLISM -- BILE ACID TRANSPORT
$725,103University Of Texas Sw Med Ctr/Dallas · R37 · FY2001 · HL
The Effect of Statins on Skeletal Muscle Function
$725,084Paul Davis Thompson · Hartford Hospital · R01 · FY2010 · HL
Cell mechanics and mechanical transduction by ion channels
$725,058Frederick Sachs · State University Of New York At Buffalo · R01 · FY2009 · HL
Center for American Indian and Alaska Native Diabetes Translation Research (CAIANDTR)
$725,000Spero M Manson · University Of Colorado Denver · P30 · FY2022 · DK